Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 12.180 | 12.180 | 0.000 |
Shares | 88.320 | 88.320 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.772 | 21.169 |
Price to Book | 2.509 | 2.532 |
Price to Sales | 1.699 | 2.940 |
Price to Cash Flow | 12.819 | 12.483 |
Dividend Yield | 1.577 | 2.224 |
5 Years Earnings Growth | 14.466 | 11.690 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 92.130 | 97.348 |
Industrials | 6.030 | 0.866 |
Consumer Defensive | 1.840 | 0.895 |
Number of long holdings: 69
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 7.41 | 48.27 | -3.83% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 5.31 | 263.31 | -3.20% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 4.91 | 64.04 | -5.67% | |
Kelun Pharm A | CNE100000PW7 | 4.83 | 30.49 | -3.57% | |
Ningbo Sanxing Medical Electric | CNE100001567 | 4.83 | 32.19 | -2.95% | |
Beijing Strong Biotech | CNE100001Y26 | 4.75 | 14.00 | -5.72% | |
RemeGen | CNE100005B03 | 4.62 | 34.15 | -7.25% | |
Humanwell Healthcare | CNE000000QW6 | 2.88 | 22.49 | -5.50% | |
Salubris Pharm A | CNE100000FW8 | 2.67 | 31.73 | -3.99% | |
Sunshine Guojian Pharmaceutical Shanghai Co | CNE1000062X2 | 2.56 | 22.40 | -5.49% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ABC-CA New Energy Theme mix | 9.75B | 3.55 | -20.66 | - | ||
ABC-CA Industry 4.0 Alloc | 2.93B | 10.62 | -12.21 | - | ||
ABC CA Research Selection Fund | 2.58B | -6.14 | -16.59 | 12.09 | ||
ABC-CA Selected Strategies Equity | 2.57B | 6.78 | -13.64 | 4.41 | ||
ABC CA Sector Growth Equity Fd A | 1.36B | 5.82 | -13.13 | 4.43 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review